Replies to post #1217 on Axim Biotechnologies Inc (AXIM)

[Buddy124]

Totally agree.

I believe as the regular need for antibody measurenent increases worldwide, Axim will be uniquely qualified and situated to fill the nitch by measuring the DEGREE of antibodies. It is not a binary test. We are learning the antibody count fluctuates from person in reaction to their chemistry. Also, antibodies do not stay in your system forever.

I know I would want a regular rehoming of these for my kids and parents. This may be the best way in existence to tell you if you have sars2 and/or the requisite amount of antibodies to dispatch the virus.

Not to mention they just added a guy who was at the White House.

The FDA states on line in some instances they can approve EUAs in a matter of hours. This one needs no human testing and their is an immediate need as vaccine trials progress worldwide.

I have my money. I am in investor because I see no negatives. Their stated results are near identical to the blood tests.

[Buddy124]

I believe $AXIM has been skimpy with the PR or else this would already be much higher. You really have to dig for the info. I don't blame them. It's all hands on deck in these situations.

[StockRoomBully]

He got an agenda its that simple. Same thing that happended in $Ino big blah blah and same will happend here. Desperation posting on a Sunday stays it all.


The demand of this test and the demand of monitoring antibodies is what is needed going forward.


This test will work with big manufacturers pharma vaccine clinical trials. Get it?

He knows. Everyone hedge fund knows hence the $million dollar non ihub VOLUME so before it get to $7.00 folks gonna shake the weak and vulnerable

Oh not to mention $Axim just added "Former Secretary of Veterans Affairs Peter O'Rourke to Company’s Board of Directors"

Now hedge fund$ see $$$$$ and they're LOADING.

“As we move into new, exciting but uncharted territory of helping with the COVID-19 crisis, we believe that Peter will help us make the smartest, most efficient evaluations on our present and future operations.”

A-Team